Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system
Objective In 2017, the Italian Medicines Agency (Agenzia Italiana del Farmaco, AIFA) introduced a standardised process to appraise innovativeness of medicines. Innovative medicines are provided speeder market access and dedicated funds. Innovativeness criteria are: unmet therapeutic need, added ther...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/11/1/e041259.full |